证券代码：688488 证券简称：艾迪药业 公告编号：2025-044 江苏艾迪药业集团股份有限公司 关于调整 2025 年股票期权激励计划相关事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏艾迪药业集团股份有限公司《2025 年股票期权激励计划（草案）》（以 下简称"《激励计划（草案）》"或"本激励计划"）规定的公司 2025 年股票 期权激励计划首次授予条件已经成就，根据江苏艾迪药业集团股份有限公司（以 下简称"公司"或"艾迪药业"）2025 年第二次临时股东会授权，公司于 2025 年 8 月 14 日召开第三届董事会第五次会议和第三届监事会第五次会议，审议通 过了《关于调整 2025 年股票期权激励计划相关事项的议案》。现将有关事项说 明如下： 一、已履行的决策程序和信息披露情况 了《关于公司<2025 年股票期权激励计划（草案）>及其摘要的议案》《关于公 司<2025 年股票期权激励计划实施考核管理办法>的议案》《关于提请股东会授 权董事会办理公司 2025 年股票期权激励计划相关事宜的议案》，相 ...

Core Points - The company has conducted a review of the initial grant list for the 2025 stock option incentive plan, confirming that it aligns with the approved draft by the second extraordinary general meeting of shareholders in 2025 [1][2] - A total of 8.96 million stock options will be granted to 43 incentive recipients, with an exercise price set at 13.01 yuan per option, effective from August 14, 2025 [2] Summary by Categories Incentive Recipients - The list of incentive recipients is consistent with the conditions outlined in the company's 2025 stock option incentive plan draft [1][2] - The recipients meet the qualifications as per relevant laws, regulations, and the company's articles of association [2] Compliance and Regulations - The review confirms that none of the recipients fall under categories that would disqualify them from receiving stock options, such as being deemed inappropriate by the securities exchange or regulatory authorities within the last 12 months [1][2] - The review adheres to the stipulations set forth in the Company Law, Securities Law, and other regulatory frameworks [1][2]

江苏艾迪药业集团股份有限公司 董事、总裁、首席执行 （截至授予日） 官 公司 2025 年股票期权激励计划首次授予的股票期权在各激励对象间的分配 情况如下表： | | | | 获授的股票 | | 占首次授 | | 占本激励计划 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 序 | | | | | | | | | | 姓名 | 国籍 | 职务 | | 期权数量 | | 予权益总 | | 公告时股本总 | | 号 | | | | | | | | | | | | | （万份） | | 数的比例 | | 额的比例 | | | 首次授予部分 | | | | | | | | | 授予数量作相应调整，可以将该激励对象放弃的权益份额直接调减或在其他激励对象之间进 行分配。 露前确定，经董事会提出、监事会发表明确意见、律师发表专业意见并出具法律意见书后， 公司在指定网站按要求及时准确披露当次激励对象相关信息。 江苏艾迪药业集团股份有限公司董事会 核心技术（业务）骨干人员（37 人） 436.00 48.661% 1.036% 首次授予合计 896.0 ...

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng (Hangzhou) Law Firm confirms that Zhejiang Nandu Power Source Co., Ltd.'s cancellation of certain stock options under the 2022 Stock Option Incentive Plan has been properly authorized and complies with relevant laws and regulations [1][8]. Group 1: Authorization and Approval of Cancellation - The company has obtained necessary approvals for the cancellation of stock options, including resolutions from the board of directors and the third extraordinary general meeting of shareholders [4][8]. - The independent directors provided opinions affirming that the incentive plan is beneficial for the company's sustainable development and does not harm the interests of the company and all shareholders [4][5]. Group 2: Details of the Cancellation - A total of 1,082,996 stock options were canceled due to 24 individuals leaving the company and 4 individuals not meeting performance criteria [5][6]. - The total number of stock options that were not exercised by the end of the first exercise period was 7,249,140, with 12,882,602 options canceled due to similar reasons in the second exercise period [6][7]. - The company has also canceled 14,088,276 stock options from the third exercise period due to unmet performance targets [7][8]. Group 3: Compliance with Regulations - The cancellation process adheres to the provisions of the Company Law, Securities Law, and relevant incentive plan regulations, ensuring that it does not materially affect the company's financial status or operational results [8].

Core Viewpoint - The company has announced the cancellation of a portion of stock options from its 2022 stock option incentive plan due to various reasons including employee departures and unmet performance criteria [1][3][6]. Group 1: Stock Option Incentive Plan Overview - The 2022 stock option incentive plan was approved through a series of board meetings and received necessary legal and financial opinions [1][2]. - The plan included a public disclosure of the list of incentive recipients, which was free of objections during the public comment period [2]. Group 2: Cancellation Details - A total of 1,208,445 stock options will be canceled, which includes 1,082,996 options from 24 departing employees and 125,449 options from 6 employees who did not meet performance criteria [3][6]. - The first exercise period of the plan allowed 394 eligible recipients to exercise a total of 16,289,296 stock options [3]. Group 3: Impact and Compliance - The cancellation of stock options is not expected to have a significant impact on the company's financial status or operational results [6][8]. - The company has followed all necessary legal procedures and regulations regarding the cancellation of stock options, ensuring compliance with relevant laws [8].

Core Points - The company held its ninth board meeting on August 14, 2025, with all seven directors present, complying with relevant laws and regulations [1][2][3] - The board approved the 2025 semi-annual report and its summary, which is available on the designated information disclosure website [1] - The board confirmed that the company has adhered to regulations regarding the storage and use of raised funds, with no violations reported [2] - The board agreed to cancel a total of 1,208,445 stock options from the 2022 stock option incentive plan that had been granted but not exercised [2][3]

证券日报网讯 8月13日晚间，山水比德发布公告称，公司于2025年8月13日分别召开第三届董事会第二 十三次会议和第三届监事会第二十三次会议，审议通过《关于调整2024年股票期权激励计划授予数量及 行权价格的议案》，根据相关规定，以及公司2024年第三次临时股东大会的授权，因公司实施2024年年 度权益分派事项，本激励计划的行权价格由29.68元/股调整为21.20元/股，股票期权数量由387.84万份调 整为542.976万份。 （文章来源：证券日报） ...

Group 1 - The board of directors of Guangzhou Shanshui Bide Design Co., Ltd. held its 23rd meeting of the third session on August 13, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2] - The board approved the adjustment of the 2024 stock option incentive plan, changing the exercise price from 29.68 yuan per share to 21.20 yuan per share and increasing the number of stock options from 3.8784 million to 5.42976 million [1][2] - The board also approved the achievement of the exercise conditions for the first exercise period of the 2024 stock option incentive plan, allowing 39 eligible participants to exercise a total of 2.71488 million stock options [2]

Group 1 - The third meeting of the supervisory board of Guangzhou Shanshui Bide Design Co., Ltd. was held on August 13, 2025, with all three supervisors present, confirming the legality and validity of the meeting procedures [1][2] - The supervisory board approved the adjustment of the number of stock options and exercise price for the 2024 stock option incentive plan, stating that the adjustments comply with relevant laws and regulations [1][2] - The supervisory board also approved the achievement of exercise conditions for the first exercise period of the 2024 stock option incentive plan, allowing 39 eligible participants to exercise a total of 2.71488 million stock options [2]

Core Viewpoint - The report outlines the adjustments to the stock option incentive plan of Guangzhou Shanshui Bide Design Co., Ltd., detailing the necessary procedures, adjustments in stock option quantities and exercise prices, and the conditions for the first exercise period [2][4][5]. Group 1: Incentive Plan Overview - The independent financial advisor, Shenzhen Tashan Enterprise Management Consulting Co., Ltd., has been commissioned to provide a report on the stock option incentive plan for 2024 [2]. - The plan includes provisions for stock options granted to incentive participants, with specific conditions for exercising these options [2][3]. Group 2: Adjustment Details - The stock option quantity and exercise price will be adjusted in response to corporate actions such as capital reserve transfers, stock dividends, and stock splits [4]. - Following the implementation of the 2024 annual equity distribution plan, the total stock options granted will be adjusted to 5.42976 million, with an exercise price set at 21.20 yuan per share [5]. Group 3: Conditions for Exercise - The first exercise period for the stock options is contingent upon the company meeting specific performance criteria, including a minimum revenue growth of 10% compared to the previous year [6]. - The company reported a revenue of 459.26 million yuan in 2023, with a target for 2024 to achieve a revenue growth of 37.84% and a net profit of at least 10 million yuan [6][7]. Group 4: Performance Assessment - A total of 39 incentive participants are eligible for the first exercise period, with the performance assessment indicating that 3 individuals received an "excellent" rating and 36 received a "good" rating, allowing for full exercise of their options [8]. - The actual number of stock options available for exercise is calculated based on the performance results of the participants [8]. Group 5: Conclusion and Compliance - The independent financial advisor concludes that the adjustments to the stock options and the conditions for the first exercise period have complied with relevant regulations and necessary procedures [9]. - The company must apply to the Shenzhen Stock Exchange and the China Securities Depository and Clearing Corporation for the adjustment and exercise procedures [9].